Abo Bibliothek: Guest
Critical Reviews™ in Immunology

Erscheint 6 Ausgaben pro Jahr

ISSN Druckformat: 1040-8401

ISSN Online: 2162-6472

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 1.3 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 2.6 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00079 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.24 SJR: 0.429 SNIP: 0.287 CiteScore™:: 2.7 H-Index: 81

Indexed in

Immune Cell Functions in Pancreatic Cancer

Volumen 20, Ausgabe 5, 2000, 18 pages
DOI: 10.1615/CritRevImmunol.v20.i5.20
Get accessGet access

ABSTRAKT

Pancreatic cancer kills nearly 29,000 people in the United States annually—as many people as are diagnosed with the disease. Chemotherapeutic treatment is ineffective in halting progression of the disease. Yet, specific immunity to pancreatic tumor cells in subjects with pancreatic cancer has been demonstrated repeatedly during the last 24 years. Attempts to expand and enhance tumor-specific immunity with biotherapy, however, have not met with success. The question remains, "Why can't specific immunity regulate pancreatic cancer growth?" The idea that tumor cells have evolved protective mechanisms against immunity was raised years ago and has recently been revisited by a number of research laboratories. In pancreatic cancer, soluble factors produced by and for the protection of the tumor environment have been detected and are often distributed to the victim's circulatory system where they may effect a more generalized immunosuppression. Yet the nature of these soluble factors remains controversial, since some also serve as tumor antigens that are recognized by the same T cells that may become inactivated by them. Unless the problem of tumor-derived immunosuppressive products is addressed directly through basic and translational research studies, successful biotherapeutic treatment for pancreatic cancer may not be forthcoming.

REFERENZIERT VON
  1. Plate Janet, Clinical trials of vaccines for immunotherapy in pancreatic cancer, Expert Review of Vaccines, 10, 6, 2011. Crossref

  2. Plate Janet M.D., Harris Jules E., Immunobiotherapy directed against mutated and aberrantly expressed gene products in pancreas cancer, Journal of Cellular Biochemistry, 94, 6, 2005. Crossref

  3. Ishii Genichiro, Sangai Takafumi, Ito Takashi, Hasebe Takahiro, Endoh Yasushi, Sasaki Hiroki, Harigaya Kenichi, Ochiai Atsushi, In vivo andin vitro characterization of human fibroblasts recruited selectively into human cancer stroma, International Journal of Cancer, 117, 2, 2005. Crossref

  4. Plate Janet M. D., Plate Aileen E., Shott Susan, Bograd Susan, Harris Jules E., Effect of gemcitabine on immune cells in subjects with adenocarcinoma of the pancreas, Cancer Immunology, Immunotherapy, 54, 9, 2005. Crossref

  5. Tseng Jennifer F., Willett Christopher G., Castillo Carlos Fernandez-del, Ryan David P., Clark Jeffrey W., Zhu Andrew X., Rattner David W., Winkelmann Jennifer L., Warshaw Andrew L., Patients undergoing treatment for pancreatic adenocarcinoma can mount an effective immune response to vaccinations, Pancreatology, 5, 1, 2005. Crossref

  6. Cubillos-Ruiz Juan R., Engle Xavier, Scarlett Uciane K., Martinez Diana, Barber Amorette, Elgueta Raul, Wang, Li, Nesbeth Yolanda, Durant, Yvon, Gewirtz Andrew T., Sentman Charles L., Kedl Ross, Conejo-Garcia Jose R., Polyethylenimine-based siRNA nanocomplexes reprogram tumor-associated dendritic cells via TLR5 to elicit therapeutic antitumor immunity, Journal of Clinical Investigation, 2009. Crossref

  7. Degrate Luca, Nobili Cinzia, Franciosi Claudio, Caprotti Roberto, Brivio Fernando, Romano Fabrizio, Leone Biagio Eugenio, Trezzi Rosangela, Uggeri Franco, Interleukin-2 immunotherapy action on innate immunity cells in peripheral blood and tumoral tissue of pancreatic adenocarcinoma patients, Langenbeck's Archives of Surgery, 394, 1, 2009. Crossref

  8. Morse Michael A, Hall Joseph Robert, Plate Janet MD, Countering tumor-induced immunosuppression during immunotherapy for pancreatic cancer, Expert Opinion on Biological Therapy, 9, 3, 2009. Crossref

  9. Plate Janet M.D., Current Immunotherapeutic Strategies in Pancreatic Cancer, Surgical Oncology Clinics of North America, 16, 4, 2007. Crossref

  10. Almhanna Khaldoun, Philip Philip A., Defining New Paradigms for the Treatment of Pancreatic Cancer, Current Treatment Options in Oncology, 12, 2, 2011. Crossref

  11. Chu Carrie K., Sarmiento Juan M., Park Jaemin, Staley Charles A., Galloway John R., Adsay N. Volkan, Kooby David A., Differences in Presentation and Perioperative Outcome after Pancreaticoduodenectomy for Cancer and Benign Pancreatitis, The American Surgeon, 76, 6, 2010. Crossref

  12. Storz Peter, Crawford Howard C., Carcinogenesis of Pancreatic Ductal Adenocarcinoma, Gastroenterology, 158, 8, 2020. Crossref

  13. Markus M., Abendroth A., Noureddine R., Paul A., Breitenbuecher S., Virchow I., Schmid K. W., Markus P., Schumacher B., Wiesweg M., Wendling J., Mende B., Siveke J. T., Schuler M., Kasper S., Combined systemic inflammation score (SIS) correlates with prognosis in patients with advanced pancreatic cancer receiving palliative chemotherapy, Journal of Cancer Research and Clinical Oncology, 147, 2, 2021. Crossref

  14. Baird Jason R., Fox Barbara A., Sanders Kiah L., Lizotte Patrick H., Cubillos-Ruiz Juan R., Scarlett Uciane K., Rutkowski Melanie R., Conejo-Garcia Jose R., Fiering Steven, Bzik David J., Avirulent Toxoplasma gondii Generates Therapeutic Antitumor Immunity by Reversing Immunosuppression in the Ovarian Cancer Microenvironment, Cancer Research, 73, 13, 2013. Crossref

  15. Catanzaro Elena, Canistro Donatella, Pellicioni Valentina, Vivarelli Fabio, Fimognari Carmela, Anticancer potential of allicin: A review, Pharmacological Research, 177, 2022. Crossref

  16. Liu Cunren, Yu Shaohua, Zinn Kurt, Wang Jianhua, Zhang Liming, Jia Yujiang, Kappes John C., Barnes Stephen, Kimberly Robert P., Grizzle William E., Zhang Huang-Ge, Murine Mammary Carcinoma Exosomes Promote Tumor Growth by Suppression of NK Cell Function, The Journal of Immunology, 176, 3, 2006. Crossref

Zukünftige Artikel

Identification of a novel five-gene prognostic model for laryngeal cancer associated with mitophagy using integrated bioinformatics analysis and experimental verification Dong Song, Lun Dong, Mei Wang, Xiaoping Gao Function of steroid receptor coactivators (SRCs) in T cells and cancers: Implications for cancer immunotherapy Wencan Zhang, Xu Cao, Hongmin Wu, Xiancai Zhong, Yun Shi, Zuoming Sun Electroacupuncture Alleviates Ischemic Stroke by Activating the mTOR/SREBP1 Pathway Jiawang Lang, Jianchang Luo, Luodan Wang, Wenbin Xu, Jie Jia, Zhipeng Zhao, Boxu Lang KIAA1429 induces the m6A modification of LINC01106 to enhance the malignancy of lung adenocarcinoma cell via JAK/STAT3 pathway Di Xu, Ziming Wang, Fajiu Li Effect of p-estrogen receptor at serine on its function and breast growth Yuan Liang, Junhui Qin, Tiancheng Ma, Tong Yang, Zhenyu Ke, Ruian Wang Mechanistic Insights into Tanshinone IIA in the Amelioration of Post-Thyroidectomy Hypoparathyroidism Xiaoyu Qian, Lin Li, Liang Chen, Chao Shen, Jian Tang MiRNA let-7d-5p alleviates inflammatory responses by targeting Map3k1 and inactivating ERK/p38 MAPK signaling in microglia Fan Fang, Cheng Chen Role of Natural Killer Cells as Cell-Based Immunotherapy in Oral Tumor Eradication and Differentiation Both In Vivo and In Vitro Kawaljit Kaur, Anahid Jewett The Current and Future States of Natural Killer Cell-Based Immunotherapy in Hepatocellular Carcinoma Tu Nguyen, Po-Chun Chen, Janet Pham, Kawaljit Kaur, Steven Raman, Anahid Jewett, Jason Chiang Phillygenin alleviated arthritis through the inhibition of NLRP3 inflammasome and Ferroptosis by AMPK Jianghui Wang, Shufang Ni, Kai Zheng, Yan Zhao, peihong zhang, Hong Chang The value of systemic immune-inflammation index and T cell subsets in the severity and prognosis of sepsis Hao Zhou Efficacy and Nuances of Precision Molecular Engineering for Hodgkin's Disease to a Gene Therapeutic Approach Muhammad Imran Qadir, Bilal Ahmed, Nadir Hussain Serum interleukin 6 and ferritin levels are the independent risk factors for pneumonia in elderly patients Hao Yuan, Jing Tian, Lu Wen Exploration of diagnostic markers associated with inflammation in chronic kidney disease (CKD) based on WGCNA and machine learning Qianjia Wu, Yang Yang, Chongze Lin Clinical significance of serum CTRP3 level in the prediction of cardiac dysfunction and intestinal mucosal barrier dysfunction in patients with severe acute pancreatitis Qiang Shao, Lin Sun The protective effect and mechanism of mild hypothermia on pig lung injury after cardiopulmonary resuscitation Jinlin Ren, Fangfang Zhu, Dongdong Sang, Mulin Cong, Shujuan Jiang Exploring mechanism of Zilongjin in treating lung adenocarcinoma based on network pharmacology combined with experimental verification Kang Zhang, Xiaoqun Chen Gastric Cancer Immune Subtypes and Prognostic Modeling: Insights from Aging-Related Genes Analysis Jian Shen, Minzhe Li Effects of different doses of dexmedetomidine on the prevention of postoperative sleep disturbance and serum neurotransmitter level in patients under general anesthesia Huifei Lu, Fei He, Ying Huang, Zhongliang Wei Identification of key ubiquitination-related genes and their associated with immune infiltration in osteoarthritis based on mRNA-miRNA network Dalu Yuan, Hailiang Shen, Lina Bai, Menglin Li, Qiujie Ye Diagnostic and Prognostic value of peripheral neutrophil CD64 index in elderly patients with community-acquired pneumonia Yan Li, Jing Zhang, Suhang Wang, Jie Cao Identification of Metabolism-Related Prognostic Biomarkers and Immune Features of Head and Neck Squamous Cell Carcinoma Rongjin Zhou, Junguo Wang Downregulation of miR-503-5p promotes the development of pancreatic cancer via targeting cyclin E2 Fei Li, Ying-pei Ling, Pan Wang, Shi-cheng Gu, Hao Jiang, Jie Zhu
Digitales Portal Digitale Bibliothek eBooks Zeitschriften Referenzen und Berichte Forschungssammlungen Preise und Aborichtlinien Begell House Kontakt Language English 中文 Русский Português German French Spain